{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:43:41Z","timestamp":1793497421610,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0409-3","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T05:54:51Z","timestamp":1493272491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":252,"title":["The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA"],"prefix":"10.1186","volume":"17","author":[{"given":"Robert Y.","family":"Suruki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas B.","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Boudiaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"409_CR1","unstructured":"World Health Organization: Bronchial Asthma; Web link: \nhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs307\/en\/\n\n. Accessed 2 Oct 2015."},{"key":"409_CR2","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; Web Link: \nhttp:\/\/ginasthma.org\/2017-gina-report-global-strategy-for-asthma-management-and-prevention\/\n\n. (Accessed 22 Mar 2017)."},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371:1198\u2013207.","journal-title":"N Engl J Med"},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","volume":"380","author":"ID Pavord","year":"2012","unstructured":"Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651\u20139.","journal-title":"Lancet"},{"key":"409_CR5","first-page":"CD007313","volume":"4","author":"CJ Cates","year":"2013","unstructured":"Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;4:CD007313.","journal-title":"Cochrane Database Syst Rev"},{"key":"409_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","volume":"164","author":"PM O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","volume":"337","author":"RA Pauwels","year":"1997","unstructured":"Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337:1405\u201311.","journal-title":"N Engl J Med"},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.clinthera.2013.05.012","volume":"35","author":"DS Pearlman","year":"2013","unstructured":"Pearlman DS, LaForce CF, Kaiser K. Fluticasone\/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma. Clin Ther. 2013;35:950\u201366.","journal-title":"Clin Ther"},{"key":"409_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jaip.2014.05.002","volume":"2","author":"M Schatz","year":"2014","unstructured":"Schatz M, Meckley LM, Kim M, Stockwell BT, Castro M. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. J Allergy Clin Immunol Pract. 2014;2:570\u20134. e571.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rmed.2006.07.005","volume":"101","author":"MK Miller","year":"2007","unstructured":"Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481\u20139.","journal-title":"Respir Med"},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","volume":"2","author":"RS Zeiger","year":"2014","unstructured":"Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Gossage D, Tran TN. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2:741\u201350.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/02770903.2010.535879","volume":"48","author":"TW Guilbert","year":"2011","unstructured":"Guilbert TW, Garris C, Jhingran P, Bonafede M, Tomaszewski KJ, Bonus T, Hahn RM, Schatz M. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma. 2011;48:126\u201332.","journal-title":"J Asthma"},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000338998","volume":"160","author":"S Accordini","year":"2013","unstructured":"Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, Heinrich J, Janson C, Jarvis D, Jogi R, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160:93\u2013101.","journal-title":"Int Arch Allergy Immunol"},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1378\/chest.127.5.1579","volume":"127","author":"SK Griswold","year":"2005","unstructured":"Griswold SK, Nordstrom CR, Clark S, Gaeta TJ, Price ML, Camargo Jr CA. Asthma exacerbations in North American adults: who are the \u201cfrequent fliers\u201d in the emergency department? Chest. 2005;127:1579\u201386.","journal-title":"Chest"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jaci.2012.01.039","volume":"129","author":"JI Ivanova","year":"2012","unstructured":"Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229\u201335.","journal-title":"J Allergy Clin Immunol"},{"key":"409_CR16","doi-asserted-by":"publisher","unstructured":"Zeiger RS, Schatz M, Dalal AA, Qian L, Chen W, Ngor EW, Suruki RY, Kawatkar AA: Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting. J Allergy Clin Immunol Pract. 2016;4(1):120\u20139.e3.","DOI":"10.1016\/j.jaip.2015.08.003"},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"HK Reddel","year":"2009","unstructured":"Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59\u201399.","journal-title":"Am J Respir Crit Care Med"},{"key":"409_CR18","unstructured":"British Thoracic Society. BTS\/SIGN British Guideline on the Management of Asthma, October 2014; Web Link: \nhttps:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/asthma\/btssign-asthma-guideline-2016\/\n\n. (Accessed 21 Mar 2017)."},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jaci.2011.12.974","volume":"129","author":"KE Wells","year":"2012","unstructured":"Wells KE, Peterson EL, Ahmedani BK, Severson RK, Gleason-Comstock J, Williams LK. The relationship between combination inhaled corticosteroid and long-acting beta-agonist use and severe asthma exacerbations in a diverse population. J Allergy Clin Immunol. 2012;129:1274\u20139. e1272.","journal-title":"J Allergy Clin Immunol"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JAA.S111170","volume":"9","author":"D Price","year":"2016","unstructured":"Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy. 2016;9:1\u201312.","journal-title":"J Asthma Allergy"},{"key":"409_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/ppul.20018","volume":"37","author":"M Schatz","year":"2004","unstructured":"Schatz M, Clark S, Emond JA, Schreiber D, Camargo Jr CA. Sex differences among children 2\u201313 years of age presenting at the emergency department with acute asthma. Pediatr Pulmonol. 2004;37:523\u20139.","journal-title":"Pediatr Pulmonol"},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jaip.2015.06.016","volume":"3","author":"RS Zeiger","year":"2015","unstructured":"Zeiger RS, Schatz M, Chen W, Li Q, Khatry DB, Tran TN. Adherent uncontrolled adult persistent asthma: Characteristics and asthma outcomes. J Allergy Clin Immunol Pract. 2015;3:986\u201390. e982.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0409-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T05:55:10Z","timestamp":1493272510000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0409-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0409-3","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]},"article-number":"74"}}